Startups
Toronto-based digital health firm BlueDot, has developed a first-of-its-kind, global early warning technology for infectious diseases. Using artificial and human intelligence, BlueDot’s outbreak risk platform tracks over 150 infectious diseases globally in 65 languages, around the clock and anticipates their spread and impact. They empower national and international health agencies, hospitals, and businesses to better anticipate, and respond to, emerging threats. BlueDot was among the first in the world to identify the emerging risk from, and publish a scientific paper on, COVID-19, and delivers regular critical Insights to its partners and customers worldwide to mobilize timely, effective, efficient, coordinated, and measured responses.
BlueDot was founded in 2013 by Dr. Kamran Khan, a practicing infectious disease physician, and Professor of Medicine with the Division of Infectious Diseases at the University of Toronto. Motivated by his experiences as a frontline healthcare worker during the 2003 Toronto SARS outbreak, Dr. Khan has been studying the outbreak of infectious diseases over the past 15 years to lay the scientific foundation for BlueDot’s early warning system.
BlueDot was founded in 2013 by Dr. Kamran Khan, a practicing infectious disease physician, and Professor of Medicine with the Division of Infectious Diseases at the University of Toronto. Motivated by his experiences as a frontline healthcare worker during the 2003 Toronto SARS outbreak, Dr. Khan has been studying the outbreak of infectious diseases over the past 15 years to lay the scientific foundation for BlueDot’s early warning system.
Overview
Location
Canada, Ontario, Toronto
Employees
51-200
Total raised
$7M
Founded date
2013
Investors 2
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 22
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 5, 2024 | Как наука о данных трансформирует здравоохранение | Наука о данных трансформирует медицинский сектор, подвергая фундаментальным изменениям основы мониторинга и профилактики заболеваний, диагностики и лечения. В этой статье рассматривается роль Data Science в медицинской сфере, её основные пр... |
| Aug 8, 2024 | BlueDot unveils next-gen global infectious disease surveillance solution, cutting manual detection time by nearly 90% | Short demo of BlueDot Assistant Sample Personalized Brief Powered by generative AI, users can now automate analysis and receive personalized insights; greatly reducing the time spent on manual workflows "The launch of BlueDot Assistant... |
| Jul 5, 2023 | BlueDot partners with Japan to revolutionize global infectious disease surveillance with innovative early warning system | BlueDot partners with NCGM This collaboration will empower NCGM with cutting-edge technology rooted in science, around-the-clock data-driven insights, and the foresight to be able to make critical decisions that contribute to a healthier an... |
| Apr 27, 2023 | BlueDot's latest offering empowers pharma and life science organizations to stay ahead of influenza and COVID disruptions | The intelligence products are designed to help organizations mitigate the impact of respiratory viruses like influenza and COVID-19, by providing expert guidance and valuable insights to reduce disruption and safeguard public health. TORONT... |
| Feb 21, 2023 | Climate change likely to turn New York into a breeding ground for dengue-carrying mosquitoes | Greater awareness of this risk and earlier interventions are critical in mitigating against spread. TORONTO (PRWEB) February 21, 2023 BlueDot Inc., a leading artificial and human intelligence organization for detecting, assessing, and respo... |
| Feb 12, 2023 | Weekly AiThority Roundup: Biggest Machine Learning, Robotic And Automation Updates – February 2nd Week | This is your AI Weekly Roundup today. We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and ... |
| Feb 11, 2023 | Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates 11th Feb 2023 | This is our AI Daily Roundup . We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and human-s... |
| Feb 10, 2023 | Bluedot Becomes Microsoft Partner To Provide Enterprise Organizations With Actionable Infectious Disease Intelligence, Powered By AI | This empowers organizations to gain access to timely insights and data, enabling them to assess and respond to global infectious disease threats in a manner that is commensurate with the risk BlueDot, a leading artificial and human intellig... |
| Feb 8, 2023 | BlueDot becomes Microsoft Partner to provide Enterprise organizations with actionable infectious disease intelligence, powered by AI | BlueDot becomes Microsoft Partner This will empower enterprises with the foresight to anticipate what’s coming next and make critical decisions that not only protect their business and people, but in turn contribute to a healthier, safer, a... |
Show more
Reviews 0
FAQ about BlueDot
When was BlueDot founded?
BlueDot was founded in 2013.
How much funding has BlueDot raised?
BlueDot has raised $7M in total across 1 funding round.
Who has invested in BlueDot?
Parsers VC lists 2 investors of BlueDot, among them BDC.
What has the press written about BlueDot?
Parsers VC has collected 22 articles mentioning BlueDot, among them “Как наука о данных трансформирует здравоохранение” (Sep 5, 2024) and “BlueDot unveils next-gen global infectious disease surveillance solution, cutting manual detection time by nearly 90%” (Aug 8, 2024).
Is BlueDot still active?
Yes, BlueDot is active; its latest activity on Parsers VC dates from Sep 8, 2024.